MYRIAD GENETICS INC
Ticker: 899923
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
202.70
+6.3%-1.5%
Expenditure
242.60
+5.7%+5.9%
Net Profit
-43.90
-1.6%-60.2%
OPM %
-19.68%
+0.71pp-8.36pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingMYGN
20266Nov
Board Meeting
Executive Retention Stock Option Awards approved for certain…
SEC Filing ↗ Board MeetingMYGN
20264Nov
Board Meeting
Myriad Genetics, Inc. to hold its third quarter 2026 earning…
SEC Filing ↗ Board MeetingMYGN
202616Sep
Board Meeting
Vishal Sikri promoted to Executive Vice President - Commerci…
SEC Filing ↗ Board MeetingMYGN
202630Jul
Board Meeting
Second Quarter 2026 Earnings Conference Call and Business Up…
SEC Filing ↗ Board MeetingMYGN
202617Jun
Board Meeting
Director Resignation — Daniel M. Skovronsky M.D., Ph.D. resi…
SEC Filing ↗ Board MeetingMYGN
20264Jun
Board Meeting
Myriad Genetics Inc. held its 2026 Annual Meeting of Stockho…
SEC Filing ↗ Board MeetingMYGN
20261Jun
Board Meeting
CTO Appointment — Raj Jampa appointed as Chief Technology Of…
SEC Filing ↗